Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

A description of the methods of the aspirin supplementation for pregnancy indicated risk reduction in nulliparas (ASPIRIN) study.

Hoffman MK, Goudar SS, Kodkany BS, Goco N, Koso-Thomas M, Miodovnik M, McClure EM, Wallace DD, Hemingway-Foday JJ, Tshefu A, Lokangaka A, Bose CL, Chomba E, Mwenechanya M, Carlo WA, Garces A, Krebs NF, Hambidge KM, Saleem S, Goldenberg RL, Patel A, Hibberd PL, Esamai F, Liechty EA, Silver R, Derman RJ.

BMC Pregnancy Childbirth. 2017 May 3;17(1):135. doi: 10.1186/s12884-017-1312-x.

2.

Maternal Antibodies to Herpes Virus Antigens and Risk of Gastroschisis in Offspring.

Werler MM, Parker SE, Hedman K, Gissler M, Ritvanen A, Surcel HM.

Am J Epidemiol. 2016 Dec 15;184(12):902-912. Epub 2016 Nov 17.

PMID:
27856447
3.

Decreasing prevalence and time trend of gastroschisis in 14 cities of Liaoning Province: 2006-2015.

Li N, Chen YL, Li J, Li LL, Jiang CZ, Zhou C, Liu CX, Li D, Gong TT, Wu QJ, Huang YH.

Sci Rep. 2016 Sep 14;6:33333. doi: 10.1038/srep33333.

4.

Evaluating the time trends in prevalence of exomphalos in 14 cities of Liaoning province, 2006 to 2015.

Gong TT, Wu QJ, Chen YL, Jiang CZ, Li J, Li LL, Liu CX, Li D, Zhou C, Huang YH.

Sci Rep. 2016 Sep 8;6:32901. doi: 10.1038/srep32901.

5.

Evaluation of developmental toxicity of guaifenesin using pregnant female rats.

Shabbir A, Shamsi S, Shahzad M, Butt HI, Aamir K, Iqbal J.

Indian J Pharmacol. 2016 May-Jun;48(3):264-9. doi: 10.4103/0253-7613.182891.

6.

Complications and Safety of Preconception Low-Dose Aspirin Among Women With Prior Pregnancy Losses.

Ahrens KA, Silver RM, Mumford SL, Sjaarda LA, Perkins NJ, Wactawski-Wende J, Galai N, Townsend JM, Lynch AM, Lesher LL, Faraggi D, Zarek S, Schisterman EF.

Obstet Gynecol. 2016 Apr;127(4):689-98. doi: 10.1097/AOG.0000000000001301.

7.

Histomorphological Features of Intestinal Atresia and its Clinical Correlation.

Subbarayan D, Singh M, Khurana N, Sathish A.

J Clin Diagn Res. 2015 Nov;9(11):EC26-9. doi: 10.7860/JCDR/2015/13320.6838. Epub 2015 Nov 1.

8.

Outcome of jejuno-ileal atresia associated with intraoperative finding of volvulus of small bowel.

Sinha S, Sarin YK.

J Neonatal Surg. 2012 Jul 1;1(3):37. eCollection 2012 Jul-Sep.

9.

Spatial analysis of gastroschisis in the National Birth Defects Prevention Study.

Yazdy MM, Werler MM, Feldkamp ML, Shaw GM, Mosley BS, Vieira VM; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2015 Jun;103(6):544-53. doi: 10.1002/bdra.23375. Epub 2015 Apr 6.

10.

Spatial analysis of gastroschisis in Massachusetts and Texas.

Yazdy MM, Werler MM, Anderka M, Langlois PH, Vieira VM.

Ann Epidemiol. 2015 Jan;25(1):7-14. doi: 10.1016/j.annepidem.2014.10.001. Epub 2014 Oct 13.

11.

Antihistamines and birth defects: a systematic review of the literature.

Gilboa SM, Ailes EC, Rai RP, Anderson JA, Honein MA.

Expert Opin Drug Saf. 2014 Dec;13(12):1667-98. doi: 10.1517/14740338.2014.970164. Epub 2014 Oct 11. Review.

12.

Maternal genitourinary infections and the risk of gastroschisis.

Yazdy MM, Mitchell AA, Werler MM.

Am J Epidemiol. 2014 Sep 1;180(5):518-25. doi: 10.1093/aje/kwu157. Epub 2014 Jul 29.

13.

Assessment of antihistamine use in early pregnancy and birth defects.

Li Q, Mitchell AA, Werler MM, Yau WP, Hernández-Díaz S.

J Allergy Clin Immunol Pract. 2013 Nov-Dec;1(6):666-74.e1. doi: 10.1016/j.jaip.2013.07.008. Epub 2013 Sep 12.

14.

Use of decongestants during pregnancy and the risk of birth defects.

Yau WP, Mitchell AA, Lin KJ, Werler MM, Hernández-Díaz S.

Am J Epidemiol. 2013 Jul 15;178(2):198-208. doi: 10.1093/aje/kws427. Epub 2013 Jul 3.

15.

Case-control studies for identifying novel teratogens.

Werler MM, Louik C, Mitchell AA.

Am J Med Genet C Semin Med Genet. 2011 Aug 15;157C(3):201-8. doi: 10.1002/ajmg.c.30307. Epub 2011 Jul 15.

16.

Parental risk factors and anorectal malformations: systematic review and meta-analysis.

Zwink N, Jenetzky E, Brenner H.

Orphanet J Rare Dis. 2011 May 17;6:25. doi: 10.1186/1750-1172-6-25. Review.

17.

Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis?

Werler MM, Mitchell AA, Moore CA, Honein MA; National Birth Defects Prevention Study.

Am J Med Genet A. 2009 Jul;149A(7):1399-406. doi: 10.1002/ajmg.a.32897.

18.

Maternal vasoactive exposures, amniotic bands, and terminal transverse limb defects.

Werler MM, Bosco JL, Shapira SK; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2009 Jan;85(1):52-7. doi: 10.1002/bdra.20524.

19.

Case-control study of self reported genitourinary infections and risk of gastroschisis: findings from the national birth defects prevention study, 1997-2003.

Feldkamp ML, Reefhuis J, Kucik J, Krikov S, Wilson A, Moore CA, Carey JC, Botto LD.

BMJ. 2008 Jun 21;336(7658):1420-3. doi: 10.1136/bmj.39567.509074.25. Epub 2008 Jun 16.

20.

Ensuring the safe and effective use of medications during pregnancy: planning and prevention through preconception care.

Cragan JD, Friedman JM, Holmes LB, Uhl K, Green NS, Riley L.

Matern Child Health J. 2006 Sep;10(5 Suppl):S129-35. Epub 2006 Jul 19. Review. No abstract available.

Supplemental Content

Support Center